Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan Samuels

Showing results (61-70 of 75) with videos related to

Pageof 8
Sort By:
Arthritis & Rheumatology (Hoboken, N.J.)|July 22, 2015
Low-grade inflammation in symptomatic knee osteoarthritis: prognostic value of inflammatory plasma lipids and peripheral blood leukocyte biomarkersMukundan Attur, Svetlana Krasnokutsky, Alexander Statnikov, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 24, 2025
Associations and Diagnostic Accuracy of Ultrasound Features in Knee Osteoarthritis: Cross-Sectional Results From a Large Community-Based CohortKatherine A Yates, Carolina Alvarez, Todd A Schwartz, et al.
Arthritis Care & Research|August 5, 2017
Musculoskeletal Ultrasound Instruction in Adult Rheumatology Fellowship ProgramsKarina D Torralba, Amy C Cannella, Eugene Y Kissin, et al.
Biomed Research International|August 23, 2014
The effect of rilonacept versus placebo on health-related quality of life in patients with poorly controlled familial Mediterranean feverPhilip J Hashkes, Steven J Spalding, Rula Hajj-Ali, et al.
Annals of the Rheumatic Diseases|July 6, 2021
14-3-3 epsilon is an intracellular component of TNFR2 receptor complex and its activation protects against osteoarthritisWenyu Fu, Aubryanna Hettinghouse, Yujianan Chen, et al.
Annals of Internal Medicine|October 17, 2012
Rilonacept for colchicine-resistant or -intolerant familial Mediterranean fever: a randomized trialPhilip J Hashkes, Steven J Spalding, Edward H Giannini, et al.
Rheumatology (Oxford, England)|May 31, 2022
Low incidence and transient elevation of autoantibodies post mRNA COVID-19 vaccination in inflammatory arthritisRebecca B Blank, Rebecca H Haberman, Kun Qian, et al.
Nature|January 3, 2024
Na<sub>v</sub>1.7 as a chondrocyte regulator and therapeutic target for osteoarthritisWenyu Fu, Dmytro Vasylyev, Yufei Bi, et al.
BMJ Open|December 23, 2022
Efficacy of guselkumab, a selective IL-23 inhibitor, in Preventing Arthritis in a Multicentre Psoriasis At-Risk cohort (PAMPA): protocol of a randomised, double-blind, placebo controlled multicentre trialRebecca H Haberman, Katrina A MacFarlane, Sydney Catron, et al.
The Lancet. Rheumatology|April 11, 2022
Methotrexate and TNF inhibitors affect long-term immunogenicity to COVID-19 vaccination in patients with immune-mediated inflammatory diseaseRebecca H Haberman, Seungha Um, Jordan E Axelrad, et al.
Pageof 8

Showing results (61-70 of 75) with videos related to

Sort By:
Pageof 8
Arthritis & Rheumatology (Hoboken, N.J.)|July 22, 2015
Low-grade inflammation in symptomatic knee osteoarthritis: prognostic value of inflammatory plasma lipids and peripheral blood leukocyte biomarkersMukundan Attur, Svetlana Krasnokutsky, Alexander Statnikov, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 24, 2025
Associations and Diagnostic Accuracy of Ultrasound Features in Knee Osteoarthritis: Cross-Sectional Results From a Large Community-Based CohortKatherine A Yates, Carolina Alvarez, Todd A Schwartz, et al.
Arthritis Care & Research|August 5, 2017
Musculoskeletal Ultrasound Instruction in Adult Rheumatology Fellowship ProgramsKarina D Torralba, Amy C Cannella, Eugene Y Kissin, et al.
Biomed Research International|August 23, 2014
The effect of rilonacept versus placebo on health-related quality of life in patients with poorly controlled familial Mediterranean feverPhilip J Hashkes, Steven J Spalding, Rula Hajj-Ali, et al.
Annals of the Rheumatic Diseases|July 6, 2021
14-3-3 epsilon is an intracellular component of TNFR2 receptor complex and its activation protects against osteoarthritisWenyu Fu, Aubryanna Hettinghouse, Yujianan Chen, et al.
Annals of Internal Medicine|October 17, 2012
Rilonacept for colchicine-resistant or -intolerant familial Mediterranean fever: a randomized trialPhilip J Hashkes, Steven J Spalding, Edward H Giannini, et al.
Rheumatology (Oxford, England)|May 31, 2022
Low incidence and transient elevation of autoantibodies post mRNA COVID-19 vaccination in inflammatory arthritisRebecca B Blank, Rebecca H Haberman, Kun Qian, et al.
Nature|January 3, 2024
Na<sub>v</sub>1.7 as a chondrocyte regulator and therapeutic target for osteoarthritisWenyu Fu, Dmytro Vasylyev, Yufei Bi, et al.
BMJ Open|December 23, 2022
Efficacy of guselkumab, a selective IL-23 inhibitor, in Preventing Arthritis in a Multicentre Psoriasis At-Risk cohort (PAMPA): protocol of a randomised, double-blind, placebo controlled multicentre trialRebecca H Haberman, Katrina A MacFarlane, Sydney Catron, et al.
The Lancet. Rheumatology|April 11, 2022
Methotrexate and TNF inhibitors affect long-term immunogenicity to COVID-19 vaccination in patients with immune-mediated inflammatory diseaseRebecca H Haberman, Seungha Um, Jordan E Axelrad, et al.
Pageof 8